It was shown that 86% of mice vaccinated with cancer membrane‐coated nanoparticles remained tumor‐free survival for over 150 d, which was more efficient than a mixture of whole B16‐F10 cells and free CpG.133 In another example, researchers developed an APC‐targeted nanoparticle by using mannose‐modified cancer cell membranes and TLR7‐loaded PLGA nanoparticles. This evidence concerns the gene APC and neoplasm.